AAAAAA

   
Results: 1-16 |
Results: 16
IMPORTANCE OF CHRONOPHARMACOKINETICS IN DESIGN AND EVALUATION OF TRANSDERMAL DRUG-DELIVERY SYSTEMS
Authors: GRIES JM BENOWITZ N VEROTTA D
Citation: Jm. Gries et al., IMPORTANCE OF CHRONOPHARMACOKINETICS IN DESIGN AND EVALUATION OF TRANSDERMAL DRUG-DELIVERY SYSTEMS, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 457-463
PHARMACOKINETICS OF SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY
Authors: VANHOVE GF KASTRISSIOS H GRIES JM VEROTTA D PARK KS COLLIER AC SQUIRES K SHEINER LB BLASCHKE TF
Citation: Gf. Vanhove et al., PHARMACOKINETICS OF SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2428-2432
EXPOSURE-RESPONSE RELATIONSHIPS FOR SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY
Authors: VANHOVE GF GRIES JM VEROTTA D SHEINER LB COOMBS R COLLIER AC BLASCHKE TF
Citation: Gf. Vanhove et al., EXPOSURE-RESPONSE RELATIONSHIPS FOR SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2433-2438
IMPORTANCE OF CHRONOPHARMACOKINETICS IN DESIGN AND EVALUATION OF TRANSDERMAL DRUG-DELIVERY SYSTEMS
Authors: GRIES JM BENOWITZ NL VEROTTA D
Citation: Jm. Gries et al., IMPORTANCE OF CHRONOPHARMACOKINETICS IN DESIGN AND EVALUATION OF TRANSDERMAL DRUG-DELIVERY SYSTEMS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 63-63
PK PD MODELING OF RECOMBINANT HUMAN CHORIONIC-GONADOTROPIN ON TESTOSTERONE PRODUCTION/
Authors: GRIES JM MUNAFO A VEROTTA D
Citation: Jm. Gries et al., PK PD MODELING OF RECOMBINANT HUMAN CHORIONIC-GONADOTROPIN ON TESTOSTERONE PRODUCTION/, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 64-64
A POOLED ANALYSIS OF CD4 RESPONSE TO ZIDOVUDINE AND ZALCITABINE TREATMENT IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX
Authors: GRIES JM TROCONIZ IF VEROTTA D JACOBSON M SHEINER LB
Citation: Jm. Gries et al., A POOLED ANALYSIS OF CD4 RESPONSE TO ZIDOVUDINE AND ZALCITABINE TREATMENT IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 70-82
A DESCRIPTIVE TOOL TO CHARACTERIZE NONLINEAR KINETICS, WITH APPLICATIONS TO MEPERIDINE AND LIDOCAINE
Authors: GRIES JM UPTON R HUANG YF VEROTTA D
Citation: Jm. Gries et al., A DESCRIPTIVE TOOL TO CHARACTERIZE NONLINEAR KINETICS, WITH APPLICATIONS TO MEPERIDINE AND LIDOCAINE, Journal of pharmaceutical sciences, 85(4), 1996, pp. 362-368
CHRONOPHARMACOKINETICS OF NICOTINE
Authors: GRIES JM BENOWITZ N VEROTTA D
Citation: Jm. Gries et al., CHRONOPHARMACOKINETICS OF NICOTINE, Clinical pharmacology and therapeutics, 60(4), 1996, pp. 385-395
VIRAL AND IMMUNOLOGICAL RESPONSES DURING COMBINATION THERAPY WITH ZDVAND EITHER DDC, SAQUINAVIR OR BOTH
Authors: VANHOVE GF GRIES JM VEROTTA D BLASCHKE TF SHEINER L
Citation: Gf. Vanhove et al., VIRAL AND IMMUNOLOGICAL RESPONSES DURING COMBINATION THERAPY WITH ZDVAND EITHER DDC, SAQUINAVIR OR BOTH, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 74-74
CHRONOPHARMACOKINETICS OF NICOTINE
Authors: GRIES JM BENOWITZ NL VEROTTA D
Citation: Jm. Gries et al., CHRONOPHARMACOKINETICS OF NICOTINE, Clinical pharmacology and therapeutics, 59(2), 1996, p.
CIMETIDINE DOES NOT ALTER SPARFLOXACIN PHARMACOKINETICS
Authors: GRIES JM HONORATO J TABURET AM ALVAREZ MP SADABA B AZANZA JR SINGLAS E
Citation: Jm. Gries et al., CIMETIDINE DOES NOT ALTER SPARFLOXACIN PHARMACOKINETICS, International journal of clinical pharmacology and therapeutics, 33(11), 1995, pp. 585-587
RELATIONSHIP BETWEEN LIVER GRAFT CYTOCHRO ME-P-450 3A AND ACUTE CYCLOSPORINE-INDUCED TOXICITY IN LIVER-TRANSPLANTATION
Authors: LEMOINE A AZOULAY D KIFFEL L GRIES JM BISMUTH H DEBUIRE B BEAUNE P
Citation: A. Lemoine et al., RELATIONSHIP BETWEEN LIVER GRAFT CYTOCHRO ME-P-450 3A AND ACUTE CYCLOSPORINE-INDUCED TOXICITY IN LIVER-TRANSPLANTATION, Therapie, 49(3), 1994, pp. 279-282
INCIDENCE OF ADVERSE REACTIONS TO CYCLOSPORINE AFTER LIVER-TRANSPLANTATION IS PREDICTED BY THE 1ST BLOOD LEVEL
Authors: AZOULAY D LEMOINE A DENNISON A GRIES JM DOLIZY I CASTAING D BEAUNE P BISMUTH H
Citation: D. Azoulay et al., INCIDENCE OF ADVERSE REACTIONS TO CYCLOSPORINE AFTER LIVER-TRANSPLANTATION IS PREDICTED BY THE 1ST BLOOD LEVEL, Hepatology, 17(6), 1993, pp. 1123-1126
RELATIONSHIP BETWEEN CYTOCHROME-P-450 3A CONTENT OF ORTHOTOPICALLY TRANSPLANTED LIVER AND POSTOPERATIVE MORBIDITY
Authors: AZOULAY D LEMOINE A DENNISON A GRIES JM DOLIZY I BARBAZZA F BONHOMME L BEAUNE P BISMUTH H
Citation: D. Azoulay et al., RELATIONSHIP BETWEEN CYTOCHROME-P-450 3A CONTENT OF ORTHOTOPICALLY TRANSPLANTED LIVER AND POSTOPERATIVE MORBIDITY, Transplantation proceedings, 25(4), 1993, pp. 2630-2631
LIDOCAINE METABOLITE FORMATION IN THE LIVER-DONOR AS A PREDICTIVE TEST FOR THE SAFE AND EFFICIENT INTRODUCTION OF CYCLOSPORINE IN THE RECIPIENT
Authors: AZOULAY D LEMOINE A GRIES JM ADAM R DOLIZY I FREDJ G BEAUNE P BISMUTH H
Citation: D. Azoulay et al., LIDOCAINE METABOLITE FORMATION IN THE LIVER-DONOR AS A PREDICTIVE TEST FOR THE SAFE AND EFFICIENT INTRODUCTION OF CYCLOSPORINE IN THE RECIPIENT, Transplantation proceedings, 25(3), 1993, pp. 2275-2278
RELATIONSHIP BETWEEN GRAFT CYTOCHROME-P-450 3A CONTENT AND EARLY MORBIDITY AFTER LIVER-TRANSPLANTATION
Authors: LEMOINE A AZOULAY D GRIES JM DENNISON A CASTAING D FREDJ G DEBUIRE B GUENGERICH FP BEAUNE P BISMUTH H
Citation: A. Lemoine et al., RELATIONSHIP BETWEEN GRAFT CYTOCHROME-P-450 3A CONTENT AND EARLY MORBIDITY AFTER LIVER-TRANSPLANTATION, Transplantation, 56(6), 1993, pp. 1410-1414
Risultati: 1-16 |